NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
CALGARY, Alberta, Feb. 05, 2019 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that both the desktop and portable CompleTest™ devices, along with the related heavy metal and THCa and CBDa scopes, have been evaluated by LabTest Certification Inc. and have received the applicable Canadian Standards Association (“CSA”) and Underwriters Laboratories (“UL”) product safety certifications for North America. With certifications in-hand, the Company has commenced sales activities.
“FluroTech is committed to selling high quality products that are safe and reliable. We are proud that the design of the desktop and portable CompleTest™ devices and scopes meet all applicable safety standards set out by CSA and UL.” commented Danny Dalla-Longa, Chief Executive Officer of FluroTech. “In addition to the CSA and UL certification, all CompleTest™ devices undergo robust internal quality controls and quality assurance to ensure uniformity between devices.”
Over the past year, in-house evaluation has resulted in the collection of thousands of datapoints demonstrating that accurate, repeatable and reliable results can be achieved with the CompleTest™. Numerous workshops have also been completed with both internal and external participants to refine the CompleTest™ training programs and ensure the device is easy-to-use.
“We have completed the design verification, testing, and certification of CompleTest™ and are excited to launch into a high growth market” stated Gary Jones, Vice President of Business Development. “The CompleTest™ was unveiled to master growers and quality assurance personnel at the recent Lift Expo in Vancouver, where over 60 live demonstrations were completed demonstrating the capabilities of our devices. The Company received positive feedback from the attendees in respect of with the simplicity, speed, accuracy, and consistency of results of the product. The Company believes that The CompleTest™ provides growers with an in-house quality assurance solution that also provides the opportunity to optimize and manage potency yields of cannabis.”
With a fast, reliable, accurate and easy-to-use in-house testing device, growers can focus on precision agriculture and optimize the potency yield of their crop without waiting for quality assurance personnel or third-party lab results. Moreover, licensed producers will have data at their fingertips to ensure third-party labs are providing accurate and consistent results.
About CompleTest™
CompleTest™ is FluroTech’s flagship brand and product line. CompleTest™ is a portable, cost-effective, state-of-the-art cannabis testing device, able to provide fast, accurate and consistent testing results. It is designed for cultivators, dispensaries and anyone with an interest in precision agriculture to optimize potency yield and consumer safety to test the quality and safety of their cannabis products.
About FluroTech (TSX-V: TEST) (OTCQB: FLURF)
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.
To learn more, visit www.FluroTech.com.
Contact Information
Gary Jones
VP Business Development
403.650.9277
[email protected]
Danny Dalla-Longa
Chief Executive Officer
403.680.0644
[email protected]
FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
[email protected]
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state and may not be offered or sold within the United States or to or for the benefit or account of U.S. persons, absent such registration or an applicable exemption from such registration requirements.
Cautionary Statement Regarding Forward-Looking Information
This news release contains “forward-looking information” within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s prospective financial performance or financial position. The forward-looking information in this news release includes disclosure about the benefits of the Company’s CompleTest™ testing device.
The Company made certain material assumptions, including but not limited to prevailing market conditions and general business, economic, competitive, political and social uncertainties to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to, adverse market conditions and regulatory and other risks associated with the cannabis industry in general, and users of the CompleTest™ failing to achieve the anticipated benefits of the product. The Company cautions that the foregoing list of material risk factors and assumptions is not exhaustive.
The Company assumes no obligation to update or revise the forward-looking information in this news release, unless it is required to do so under Canadian securities legislation.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this release.
